BlackRock Investment Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-642,726
Closed -$137M 4222
2014
Q4
$137M Sell
642,726
-338,396
-34% -$67.3M 0.18% 123
2014
Q3
$175M Sell
981,122
-13,719
-1% -$2.28M 0.24% 87
2014
Q2
$168M Sell
994,841
-40,305
-4% -$6.28M 0.23% 97
2014
Q1
$128M Buy
1,035,146
+8,497
+0.8% +$1.03M 0.19% 115
2013
Q4
$114M Sell
1,026,649
-325,874
-24% -$31.1M 0.17% 123
2013
Q3
$122M Buy
1,352,523
+296,977
+28% +$26.7M 0.2% 107
2013
Q2
$88.9M Buy
+1,055,546
New +$110M 0.16% 131

Other funds holding AGN

BlackRock Investment Management's AGN Position: Q1 2015 in Review

BlackRock Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 642,726 shares — an estimated $137M sold.

BlackRock Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $175M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 642,726 Allergan Inc shares in Q1 2015, an estimated $137M.
  • BlackRock Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock Investment Management's Allergan Inc position peaked at $175M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock Investment Management's 13F filing for Q1 2015, filed 13 May 2015.